what are the top trending stocks today and why are they moving? check finviz or similar
**Top Trending Stocks Today (June 23, 2026)**
*Based on Yahoo Finance gainers and WhyIs analysis*
---
### **1. DFTX — Definium Therapeutics, Inc.**
**+49.80%** (Last: $55.80)
**Why:** Impressive clinical trial results for **oral lysergide** (LSD-based drug) in treatment-resistant depression. The company also announced a **$500 million public offering**, signaling strong growth prospects.
### **2. APGE — Apogee Therapeutics, Inc.**
**+46.66%** (Last: $31.24)
**Why:** Positive clinical data or pipeline updates (exact details not fully captured in the summary, but sentiment is strongly positive).
### **3. ORKA — Oruka Therapeutics, Inc.**
**+18.03%** (Last: $15.74)
**Why:** Positive clinical data or pipeline updates driving investor optimism.
### **4. BWIN — The Baldwin Insurance Group, Inc.**
**+16.21%** (Last: $21.01)
**Why:** Positive earnings or business updates; stock rallying despite broader market pressure.
### **5. SMCI — Super Micro Computer, Inc.**
**+15.66%** (Last: $45.07)
**Why:** Continued AI infrastructure demand and growth in the server market. The company is a key beneficiary of AI data‑center build‑outs.
### **6. KLRA — Kailera Therapeutics, Inc.**
**+14.97%** (Last: $22.88)
**Why:** Rallied on its **Nasdaq debut after an upsized $400 million IPO**. Positive sentiment around the company’s clinical pipeline.
### **7. BHVN — Biohaven Ltd.**
**+14.22%** (Last: $15.50)
**Why:** Climbing ahead of **new clinical trials**. Recent news highlights upcoming pipeline updates and a potential launch of a seizure drug.
### **8. UMC — United Microelectronics Corporation**
**+14.20%** (Last: $27.50)
**Why:** Hits an **all‑time high on new deal buzz** and reports of 18% growth in May sales. The semiconductor foundry is benefiting from strong demand.
### **9. SYRE — Spyre Therapeutics, Inc.**
**+13.56%** (Last: $100.32)
**Why:** **Deutsche Bank raised its price target to $135** (from $115) and **Wedbush raised to $100** (from $80) following positive **SPY002 (anti‑TL1A) trial results** in ulcerative colitis.
### **10. VIAV — Viavi Solutions Inc.**
**+12.23%** (Last: $52.94)
**Why:** Launched the **industry’s first AI network validation solution for Ultra Ethernet fabrics**, accelerating AI data‑center deployments. The stock also earned a new milestone and has strong analyst support.
---
### **Broader Market Context**
- **S&P 500:** -0.37%
- **Nasdaq:** -1.32%
- **Dow Jones:** +0.29%
- **Shanghai:** +0.39%
- **Hang Seng:** -1.82%
The market is mixed, with the Nasdaq under pressure while the Dow holds slightly positive. The top gainers are driven by **clinical breakthroughs, IPOs, new deals, and AI‑related product launches**.
*Note: Data sourced from Yahoo Finance (top gainers) and WhyIs.com (AI‑generated explanations). Always do your own research before making investment decisions.*